Please assess the completion status of the following clinical trial:

Trial Title: Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* History or laboratory evidence of herpes simplex infection~* Clinical evidence or suspicion of herpes simplex infection~Exclusion Criteria:~* Patients unable to swallow~* Concomitant use of probenecid~* Positive pregnancy test~Additional protocol-defined inclusion/exclusion criteria may apply. For detailed information on eligibility, please contact the study center nearest to you or call the following numbers: 1-862-778-3544 or 1-434-951-3228

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Famciclovir, pediatric oral formulation (Type: EXPERIMENTAL): single-arm

Based on this trial design, predict the completion outcome and termination type (if applicable).